# Single Versus Double Cryoballoon Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation

Study · id `cardio:ct-nct03003975` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03003975](<https://clinicaltrials.gov/study/NCT03003975>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03003975

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

## Technical summary

Registry record NCT03003975. Randomized; no masking; primary purpose treatment. Start 2014-11 (registry gives no type); primary completion 2017-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 140 participants (enrolled count; ClinicalTrials.gov record NCT03003975, source copy `cardio:ctgov-nct03003975-2017-05-09`, retrieved 2026-10-26)
- Start date: 2014-11 (registry gives no type) (ClinicalTrials.gov record NCT03003975, source copy `cardio:ctgov-nct03003975-2017-05-09`, retrieved 2026-10-26)
- Primary completion: 2017-03 (actual) (ClinicalTrials.gov record NCT03003975, source copy `cardio:ctgov-nct03003975-2017-05-09`, retrieved 2026-10-26)
- Completion: 2017-03 (actual) (ClinicalTrials.gov record NCT03003975, source copy `cardio:ctgov-nct03003975-2017-05-09`, retrieved 2026-10-26)
- Countries: Sweden (ClinicalTrials.gov record NCT03003975, source copy `cardio:ctgov-nct03003975-2017-05-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03003975-2017-05-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Single Versus Double Cryoballoon Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation
- Acronym: SD-CRYO-AF
- Condition: Atrial Fibrillation
- Intervention (Device): PVI by single cryoballoon application guided by Achieve Mapping Catheter
- Intervention (Device): PVI by 2 routine cryoballoon applications
- Lead sponsor: Uppsala University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Uppsala University Hospital (`cardio:org-uppsala-university-hospital`)

## Provenance

Content hash: bc4e5fce16799b47ca524c7c506775f7fa1bd7cffcff856dc1adccba022e43cc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
